UNSPSC 51413206: Cinepazide maleate

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y35B3VA60V. European Medicines Agency schedules Cinepazide maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01311MIG. Cinepazide maleate generally arises in the molecular formula C22H31N3O5.C4H4O4. The term 'cinepazide maleate' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule cinepazide maleate under HS 29335995 and SITC 51576.

As of Q4 2014, CINEPAZIDE MALEATE remains US FDA's Preferred Term for this commodity. SMILES: COC1CC(CC(C1OC)OC)/C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51413206 Cinepazide maleate is a Commodity code for a specific pharmaceutical active ingredient used in emergency medical applications. State and local governments procure this and related advanced life support medications primarily through fire rescue services and emergency medical systems. The Tampa Fire Rescue bid posted in April 2026 illustrates the actual scope: sealed-bid solicitations for quantities of emergency medications including vasopressors, sympathomimetics, and antiarrhythmics supplied to municipal fire departments and emergency response units. Issuing bodies under this code are primarily municipal purchasing departments acting on behalf of fire rescue services and emergency medical divisions, with occasional county-level procurement involvement. The medications are sourced as finished pharmaceutical products meeting expiration and stability requirements, with vendors responsible for replacement of expired inventory and delivery within tight timelines. Bid pricing typically includes all freight and taxes delivered to the user jurisdiction.

Recent activity centers on Florida, with the City of Tampa's April 2026 IFB for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026, estimated contract value $40,000.00) representing the most recent documented opportunity. The Tampa solicitation required sealed bids through the OpenGov eProcurement Portal for four specific medication line items totaling approximately 3,530 units, with a one-year initial term and two optional one-year renewals plus three 30-day unilateral extensions. The procurement carried a 5 percent Small Local Business Enterprise (SLBE) bid discount capped at $10,000.00 and required vendors to supply Safety Data Sheets compliant with OSHA Hazard Communication Standards. No other recent state or local opportunities under this specific code are documented in the available source material.